These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32453638)

  • 1. Excipient Enhanced Growth Aerosol Surfactant Replacement Therapy in an
    Kamga Gninzeko FJ; Valentine MS; Tho CK; Chindal SR; Boc S; Dhapare S; Momin MAM; Hassan A; Hindle M; Farkas DR; Longest PW; Heise RL
    J Aerosol Med Pulm Drug Deliv; 2020 Dec; 33(6):314-322. PubMed ID: 32453638
    [No Abstract]   [Full Text] [Related]  

  • 2. Development and Characterization of Excipient Enhanced Growth (EEG) Surfactant Powder Formulations for Treating Neonatal Respiratory Distress Syndrome.
    Boc S; Momin MAM; Farkas DR; Longest W; Hindle M
    AAPS PharmSciTech; 2021 Apr; 22(4):136. PubMed ID: 33860409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of Low Air Volume Dry Powder Inhalers (LV-DPI) when Aerosolizing Excipient Enhanced Growth (EEG) Surfactant Powder Formulations.
    Boc S; Momin MAM; Farkas DR; Longest W; Hindle M
    AAPS PharmSciTech; 2021 Apr; 22(4):135. PubMed ID: 33860378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy, dose-response, and aerosol delivery of dry powder synthetic lung surfactant treatment in surfactant-deficient rabbits and premature lambs.
    Walther FJ; Waring AJ; Otieno M; DiBlasi RM
    Respir Res; 2022 Apr; 23(1):78. PubMed ID: 35379243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effects of aerosolized pulmonary surfactant powder in a model of ventilator-induced lung injury.
    Daniher D; McCaig L; Ye Y; Veldhuizen R; Lewis J; Ma Y; Zhu J
    Int J Pharm; 2020 Jun; 583():119359. PubMed ID: 32334066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Air-Jet Dry Powder Insufflator for High-Efficiency Aerosol Delivery to Rats.
    Pangeni R; Hassan AAM; Farkas D; Sudarjat H; Longest W; Hindle M; Xu Q
    Mol Pharm; 2023 Apr; 20(4):2207-2216. PubMed ID: 36938947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient Nose-to-Lung (N2L) Aerosol Delivery with a Dry Powder Inhaler.
    Longest PW; Golshahi L; Behara SR; Tian G; Farkas DR; Hindle M
    J Aerosol Med Pulm Drug Deliv; 2015 Jun; 28(3):189-201. PubMed ID: 25192072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aerosolization characteristics of dry powder inhaler formulations for the excipient enhanced growth (EEG) application: effect of spray drying process conditions on aerosol performance.
    Son YJ; Worth Longest P; Hindle M
    Int J Pharm; 2013 Feb; 443(1-2):137-45. PubMed ID: 23313343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel continuous powder aerosolizer (CPA) for inhalative administration of highly concentrated recombinant surfactant protein-C (rSP-C) surfactant to preterm neonates.
    Pohlmann G; Iwatschenko P; Koch W; Windt H; Rast M; de Abreu MG; Taut FJ; De Muynck C
    J Aerosol Med Pulm Drug Deliv; 2013 Dec; 26(6):370-9. PubMed ID: 23421901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surfactant and corticosteroid effects on lung function in a rat model of acute lung injury.
    Chen CM; Fang CL; Chang CH
    Crit Care Med; 2001 Nov; 29(11):2169-75. PubMed ID: 11700416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From bench to bedside: in vitro and in vivo evaluation of a neonate-focused nebulized surfactant delivery strategy.
    Bianco F; Ricci F; Catozzi C; Murgia X; Schlun M; Bucholski A; Hetzer U; Bonelli S; Lombardini M; Pasini E; Nutini M; Pertile M; Minocchieri S; Simonato M; Rosa B; Pieraccini G; Moneti G; Lorenzini L; Catinella S; Villetti G; Civelli M; Pioselli B; Cogo P; Carnielli V; Dani C; Salomone F
    Respir Res; 2019 Jul; 20(1):134. PubMed ID: 31266508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dry powder aerosolization of a recombinant surfactant protein-C-based surfactant for inhalative treatment of the acutely inflamed lung.
    Ruppert C; Kuchenbuch T; Boensch M; Schmidt S; Mathes U; Hillebrand V; Henneke I; Markart P; Reiss I; Schermuly RT; Seeger W; Günther A
    Crit Care Med; 2010 Jul; 38(7):1584-91. PubMed ID: 20400897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyethylene glycol/surfactant mixtures improve lung function after HCl and endotoxin lung injuries.
    Lu KW; Taeusch HW; Robertson B; Goerke J; Clements JA
    Am J Respir Crit Care Med; 2001 Oct; 164(8 Pt 1):1531-6. PubMed ID: 11704608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of rSP-C surfactant with natural and synthetic surfactants after late treatment in a rat model of the acute respiratory distress syndrome.
    Häfner D; Germann PG; Hauschke D
    Br J Pharmacol; 1998 Jul; 124(6):1083-90. PubMed ID: 9720777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of short-term exogenous pulmonary surfactant treatment on acute lung damage associated with the intratracheal instillation of silica.
    Antonini JM; Reasor MJ
    J Toxicol Environ Health; 1994 Sep; 43(1):85-101. PubMed ID: 8078096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of a phospholipid-based protein-free surfactant and a natural bovine surfactant (SURVANTA) during pressure and volume-controlled ventilation in an improved rabbit fetus model.
    Häfner D; Kilian U; Bühler R; Beume R; Habel R
    Pulm Pharmacol; 1993 Mar; 6(1):15-25. PubMed ID: 8477152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of exogenous surfactant instillation on experimental acute lung injury.
    Harris JD; Jackson F; Moxley MA; Longmore WJ
    J Appl Physiol (1985); 1989 Apr; 66(4):1846-51. PubMed ID: 2732176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aerosol Drug Delivery During Noninvasive Positive Pressure Ventilation: Effects of Intersubject Variability and Excipient Enhanced Growth.
    Walenga RL; Longest PW; Kaviratna A; Hindle M
    J Aerosol Med Pulm Drug Deliv; 2017 Jun; 30(3):190-205. PubMed ID: 28075194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paradoxical effects of exogenous proteins on lung function in surfactant-deficient rats.
    Walther FJ; Gupta M; Mbagwu N; Hernandez-Juviel JM; Bruni R
    Exp Lung Res; 2000 Jun; 26(4):273-85. PubMed ID: 10923245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addition of alpha1-antitrypsin to surfactant improves oxygenation in surfactant-deficient rats.
    Belai Y; Hernández-Juviel JM; Bruni R; Waring AJ; Walther FJ
    Am J Respir Crit Care Med; 1999 Mar; 159(3):917-23. PubMed ID: 10051273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.